Kamillosan® is a safe product of camomile for topical application: results of patch testing consecutive patients with contact dermatitis

Autor:	S Jałońska, E Rudzki
Rok vydání:	2000
Předmět:	Allergy medicine.medical_specialty business.industry Dermatology medicine.disease Patch testing Eastern european Oral allergy syndrome Kamillosan medicine Anthemis cotula Chamomilla recutita business Contact dermatitis
Zdroj:	Journal of Dermatological Treatment. 11:161-163
ISSN:	1471-1753 0954-6634
DOI:	10.1080/09546630050517315
Popis:	BACKGROUND/AIM: Allergy to camomile is an important problem, especially in Eastern European countries. Theaim of this study was to find out whether Anthecotulid-free extracts of Chamomilla recutita - Kamillosan® - has contact allergenic potential. METHODS: The study included 982 consecutive patients with contact dermatitis: 830 were tested with Kamillosan® solution prepared according to manufacturer's instructions and 152 patients were tested with both Kamillosan® cream and Kamillosan® ointment. RESULTS: Only one patient with very high exposure to camomile tested positive for the solution, while the tests in all the other patients were negative, including one patient who was highly sensitive to Anthemis cotula . In a patient with oral allergy syndrome and immediate hypersensitivity to many plants, including camomile, patch tests with Kamillosan® ointment and Kamillosan® cream, removed after 15 min and 48 h, were negative. CONCLUSION: These results strongly suggest that Kamillosan® could be a safe constitu...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6a59104fe91b202e36c4d8c5fc17e4a6 https://doi.org/10.1080/09546630050517315 Zobrazit plný text záznamu